Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-05 4:00 pm Purchase | 2023-11-30 | 13D | Cyclerion Therapeutics, Inc. CYCN | Hecht Peter M | 840,899 26.900% | 322,435 (+62.19%) | Filing History |
| 2023-05-23 4:00 pm Purchase | 2023-05-19 | 13D | Cyclerion Therapeutics, Inc. CYCN | Hecht Peter M | 518,464 19.990% | 518,464 (New Position) | Filing History |
| 2023-05-12 08:39 am Purchase | 2023-05-11 | 13D | Cyclerion Therapeutics, Inc. CYCN | Hecht Peter M | 518,465 19.990% | 307,482 (+145.74%) | Filing History |
| 2023-04-03 07:30 am Purchase | 2023-03-31 | 13D | Cyclerion Therapeutics, Inc. CYCN | Hecht Peter M | 210,983 9.200% | 980 (+0.47%) | Filing History |
| 2022-11-21 5:00 pm Purchase | 2022-11-20 | 13D | Cyclerion Therapeutics, Inc. CYCN | Hecht Peter M | 210,003 9.200% | 30,169 (+16.78%) | Filing History |
| 2021-06-07 5:21 pm Purchase | 2021-06-03 | 13D | Cyclerion Therapeutics, Inc. CYCN | Hecht Peter M | 179,833 8.600% | 41,159 (+29.68%) | Filing History |
| 2021-05-14 4:56 pm Purchase | 2021-05-04 | 13D | Cyclerion Therapeutics, Inc. CYCN | Hecht Peter M | 138,675 7.800% | 138,675 (New Position) | Filing History |